Newer research is looking at how the anti-inflammatory effects of these drugs might be helpful to people living with neurodegenerative diseases, such as Alzheimers and Parkinsons
However, it is potentially associated with various factors, including genetic predisposition, autoimmune disorders, surgical interventions, and iatrogenic causes such as chemotherapy and radiotherapy [4, 5]
Some patients prefer to continue with compounded medication to avoid the prior authorization process and maintain continuity with their current provider
GLP-1s are on a high and not going anywhere Public awareness and patient adoption of GLP-1 and gastric inhibitory polypeptide (GIP) agonists have grown in the past couple of years as these medications evolved from Type 2 diabetes treatments to highly effective weight loss drugs approved by the Food and Drug Administration (FDA)
Peptides are simply proteins with shorter molecular chain lengths
They are not a magic solution weight loss still comes down to burning more calories than you consume